To request a free sample copy of this report, please complete the form below.

Our Clients

  • Schineder Electric
  • KSIA - Korea Semiconductor Industry Association
  • Hitachi Astemo Limited
  • Samsung Electronics
  • Halvo holdings
  • NTT corporation
  • AGC Inc
  • Siemens AG
  • Unilever
  • Merck Pharmaceuticals
  • Atlas Copco
  • Hologic - Medical Technology company
  • Novartis
  • Henkel
  • Reckitt
  • Schineder Electric
  • KSIA - Korea Semiconductor Industry Association
  • Hitachi Astemo Limited
  • Samsung Electronics
  • Halvo holdings
  • NTT corporation
  • AGC Inc
  • Siemens AG
  • Unilever
  • Merck Pharmaceuticals
  • Atlas Copco
  • Hologic - Medical Technology company
  • Novartis
  • Henkel
  • Reckitt
  • FAQs

    Global Biological Seed Treatment Market size was valued at USD 1.99 Billion in 2024 and is poised to grow from USD 2.2 Billion in 2025 to USD 5.01 Billion by 2033, growing at a CAGR of 10.8% during the forecast period (2026–2033). 

    The global biological seed treatment market is characterized by a diverse range of companies offering a variety of products. Market players focus on research and development activities to introduce innovative and effective biological seed treatment solutions. Strategic partnerships, collaborations, and mergers and acquisitions are common strategies employed by companies to enhance their market presence. Moreover, companies emphasize expanding their distribution networks and strengthening their relationships with farmers and agricultural organizations. Continuous technological advancements and product differentiation play a crucial role in maintaining a competitive edge in the market. 'Bayer AG (Germany) ', 'Syngenta AG (Switzerland) ', 'BASF SE (Germany) ', 'Corteva Agriscience (USA) ', 'Novozymes A/S (Denmark) ', 'Certis Biologicals (USA) ', 'Valent BioSciences LLC (USA) ', 'Bioceres Crop Solutions Corp. (Argentina) ', 'Sumitomo Chemical Co., Ltd. (Japan) ', 'UPL Limited (India) ', 'Koppert Biological Systems (Netherlands) ', 'Lallemand Inc. (Canada) ', 'AGROBIOS S.A. (Mexico) ', 'Rizobacter Argentina S.A. (Argentina)'

    One key market trend in the global biological seed treatment industry is the growing adoption of organic farming practices. As consumers increasingly prioritize sustainable and environmentally friendly agricultural methods, there is a rising demand for biological seed treatment products. Organic farming regulations and certifications promote the use of natural and biological inputs, driving the market growth. Additionally, the emphasis on reducing chemical residues in food production and enhancing soil health further fuels the adoption of biological seed treatments as a preferred choice for farmers worldwide.

    North America dominated the biological seed treatment market. In North America, the dominating segment is corn, as farmers in the US have recognized the significant advantages of employing biological seed treatments for corn crops. The accurate combination of microbial and fungal agents has led to remarkable yield growth of up to ten percent. The shift in consumer trends towards chemical-free crops and the emphasis on sustainable agriculture further contribute to the dominance of biological seed treatment in this region. The US market for biological seed treatment is characterized by extensive research and development activities, fostering innovation and the introduction of advanced products.

    Feedback From Our Clients

    Global Biological Seed Treatment Market

    Report ID: SQMIG15C2042

    $5,300
    BUY NOW